文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

认知行为疗法治疗肠易激综合征可引起与胃肠道症状改善相关的脑-肠-微生物组轴的双向改变。

Cognitive behavioral therapy for irritable bowel syndrome induces bidirectional alterations in the brain-gut-microbiome axis associated with gastrointestinal symptom improvement.

机构信息

G. Oppenheimer Center for Neurobiology of Stress and Resilience, UCLA, Los Angeles, CA, USA.

David Geffen School of Medicine, UCLA, Los Angeles, CA, USA.

出版信息

Microbiome. 2021 Nov 30;9(1):236. doi: 10.1186/s40168-021-01188-6.


DOI:10.1186/s40168-021-01188-6
PMID:34847963
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8630837/
Abstract

BACKGROUND: There is growing recognition that bidirectional signaling between the digestive tract and the brain contributes to irritable bowel syndrome (IBS). We recently showed in a large randomized controlled trial that cognitive behavioral therapy (CBT) reduces IBS symptom severity. This study investigated whether baseline brain and gut microbiome parameters predict CBT response and whether response is associated with changes in the brain-gut-microbiome (BGM) axis. METHODS: Eighty-four Rome III-diagnosed IBS patients receiving CBT were drawn from the Irritable Bowel Syndrome Outcome Study (IBSOS; ClinicalTrials.gov NCT00738920) for multimodal brain imaging and psychological assessments at baseline and after study completion. Fecal samples were collected at baseline and post-treatment from 34 CBT recipients for 16S rRNA gene sequencing, untargeted metabolomics, and measurement of short-chain fatty acids. Clinical measures, brain functional connectivity and microstructure, and microbiome features associated with CBT response were identified by multivariate linear and negative binomial models. RESULTS: At baseline, CBT responders had increased fecal serotonin levels, and increased Clostridiales and decreased Bacteroides compared to non-responders. A random forests classifier containing 11 microbial genera predicted CBT response with high accuracy (AUROC 0.96). Following treatment, CBT responders demonstrated reduced functional connectivity in regions of the sensorimotor, brainstem, salience, and default mode networks and changes in white matter in the basal ganglia and other structures. Brain changes correlated with microbiome shifts including Bacteroides expansion in responders. CONCLUSIONS: Pre-treatment intestinal microbiota and serotonin levels were associated with CBT response, suggesting that peripheral signals from the microbiota can modulate central processes affected by CBT that generate abdominal symptoms in IBS. CBT response is characterized by co-correlated shifts in brain networks and gut microbiome that may reflect top-down effects of the brain on the microbiome during CBT. Video abstract.

摘要

背景:越来越多的人认识到,消化道和大脑之间的双向信号传递有助于肠易激综合征(IBS)。我们最近在一项大型随机对照试验中表明,认知行为疗法(CBT)可降低 IBS 症状严重程度。本研究旨在探讨基线时大脑和肠道微生物组参数是否可预测 CBT 反应,以及反应是否与大脑-肠道-微生物组(BGM)轴的变化有关。

方法:从肠易激综合征结局研究(IBSOS;ClinicalTrials.gov NCT00738920)中抽取 84 例符合罗马 III 标准的 IBS 患者,在基线和研究完成后进行多模态脑成像和心理评估。从 34 例接受 CBT 的患者中采集基线和治疗后粪便样本,进行 16S rRNA 基因测序、非靶向代谢组学和短链脂肪酸测量。通过多元线性和负二项式模型确定与 CBT 反应相关的临床指标、大脑功能连接和微观结构以及微生物组特征。

结果:在基线时,与非反应者相比,CBT 反应者的粪便 5-羟色胺水平升高,梭状芽胞杆菌增多,拟杆菌减少。包含 11 个微生物属的随机森林分类器对 CBT 反应具有很高的准确性(AUROC 0.96)。治疗后,CBT 反应者的感觉运动、脑干、突显和默认模式网络区域的功能连接减少,基底节和其他结构的白质发生变化。大脑变化与微生物组变化相关,包括反应者中拟杆菌的扩张。

结论:治疗前肠道微生物组和 5-羟色胺水平与 CBT 反应相关,提示来自微生物组的外周信号可以调节 CBT 影响的中枢过程,从而产生 IBS 的腹部症状。CBT 反应的特征是大脑网络和肠道微生物组的共同相关变化,这可能反映了 CBT 期间大脑对微生物组的自上而下影响。视频摘要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd86/8630837/c19cf45e5eba/40168_2021_1188_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd86/8630837/8e828660af08/40168_2021_1188_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd86/8630837/0cbcd3856c28/40168_2021_1188_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd86/8630837/5aa21c12f53d/40168_2021_1188_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd86/8630837/317cfd712127/40168_2021_1188_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd86/8630837/c19cf45e5eba/40168_2021_1188_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd86/8630837/8e828660af08/40168_2021_1188_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd86/8630837/0cbcd3856c28/40168_2021_1188_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd86/8630837/5aa21c12f53d/40168_2021_1188_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd86/8630837/317cfd712127/40168_2021_1188_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd86/8630837/c19cf45e5eba/40168_2021_1188_Fig5_HTML.jpg

相似文献

[1]
Cognitive behavioral therapy for irritable bowel syndrome induces bidirectional alterations in the brain-gut-microbiome axis associated with gastrointestinal symptom improvement.

Microbiome. 2021-11-30

[2]
Multi-omics profiles of the intestinal microbiome in irritable bowel syndrome and its bowel habit subtypes.

Microbiome. 2023-1-10

[3]
Differences in gut microbial composition correlate with regional brain volumes in irritable bowel syndrome.

Microbiome. 2017-5-1

[4]
Clinical response to fecal microbiota transplantation in patients with diarrhea-predominant irritable bowel syndrome is associated with normalization of fecal microbiota composition and short-chain fatty acid levels.

Scand J Gastroenterol. 2019-6

[5]
Improvement in Gastrointestinal Symptoms After Cognitive Behavior Therapy for Refractory Irritable Bowel Syndrome.

Gastroenterology. 2018-4-25

[6]
Intestinal Microbiome in Irritable Bowel Syndrome before and after Gut-Directed Hypnotherapy.

Int J Mol Sci. 2018-11-16

[7]
Evidence for an association of gut microbial Clostridia with brain functional connectivity and gastrointestinal sensorimotor function in patients with irritable bowel syndrome, based on tripartite network analysis.

Microbiome. 2019-3-21

[8]
A multi-omic brain gut microbiome signature differs between IBS subjects with different bowel habits.

Neuropharmacology. 2023-3-1

[9]
Cognitive behavioral therapy for irritable bowel syndrome: the effects on state and trait anxiety and the autonomic nervous system during induced rectal distensions - An uncontrolled trial.

Scand J Pain. 2018-1-26

[10]
Characteristic dysbiosis of gut microbiota of Chinese patients with diarrhea-predominant irritable bowel syndrome by an insight into the pan-microbiome.

Chin Med J (Engl). 2019-4-20

引用本文的文献

[1]
From Microbial Homeostasis to Systemic Pathogenesis: A Narrative Review on Gut Flora's Role in Neuropsychiatric, Metabolic, and Cancer Disorders.

J Inflamm Res. 2025-7-5

[2]
Protocol for a Randomized Controlled Trial to Determine if Biomarkers Predict Response to a Pediatric Chronic Pain Symptom Management Program.

J Clin Med. 2025-5-5

[3]
Effectiveness of a bioenergy economy program versus mindfulness-based cognitive therapy on the severity and psychological symptoms of irritable bowel syndrome.

J Educ Health Promot. 2025-3-28

[4]
Social organization and physical environment shape the microbiome of harvester ants.

Anim Microbiome. 2025-3-19

[5]
The synthesis of the psychosocial and the physiological aspects of chronic digestive disease is at a crossroads.

Transl Gastroenterol Hepatol. 2025-1-6

[6]
Investigating the impact of microbiome-changing interventions on food decision-making: MIFOOD study protocol.

BMC Nutr. 2025-1-13

[7]
Probiotics in reducing obesity by reconfiguring the gut microbiota.

Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2024-7-28

[8]
Gut-brain axis and neuroplasticity in health and disease: a systematic review.

Radiol Med. 2025-3

[9]
Biogeographical distribution of gut microbiome composition and function is partially recapitulated by fecal transplantation into germ-free mice.

ISME J. 2025-1-2

[10]
Stress-Resilience Impacts Psychological Wellbeing: Evidence from Brain-Gut Microbiome Interactions.

Nat Ment Health. 2024-8

本文引用的文献

[1]
The Rome IV: Irritable bowel syndrome - A functional disorder.

Best Pract Res Clin Gastroenterol. 2019-7-18

[2]
Intestinal serotonin and fluoxetine exposure modulate bacterial colonization in the gut.

Nat Microbiol. 2019-9-2

[3]
Role of brain imaging in disorders of brain-gut interaction: a Rome Working Team Report.

Gut. 2019-6-7

[4]
Evidence for an association of gut microbial Clostridia with brain functional connectivity and gastrointestinal sensorimotor function in patients with irritable bowel syndrome, based on tripartite network analysis.

Microbiome. 2019-3-21

[5]
Factors Associated With Efficacy of Cognitive Behavior Therapy vs Education for Patients With Irritable Bowel Syndrome.

Clin Gastroenterol Hepatol. 2018-10-26

[6]
Changes in brain white matter structure are associated with urine proteins in urologic chronic pelvic pain syndrome (UCPPS): A MAPP Network study.

PLoS One. 2018-12-5

[7]
Durability and Decay of Treatment Benefit of Cognitive Behavioral Therapy for Irritable Bowel Syndrome: 12-Month Follow-Up.

Am J Gastroenterol. 2019-2

[8]
Manipulating the Gut Microbiome as a Treatment Strategy for Functional Gastrointestinal Disorders.

Gastroenterology. 2018-10

[9]
Effect of Antidepressants and Psychological Therapies in Irritable Bowel Syndrome: An Updated Systematic Review and Meta-Analysis.

Am J Gastroenterol. 2019-1

[10]
The Brain-Gut-Microbiome Axis.

Cell Mol Gastroenterol Hepatol. 2018-4-12

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索